根据最新的SEC文件显示，Akero Therapeutics Inc. (NASDAQ: AKRO )的首席科学官Rolph Timothy近期进行了一笔重要的股票交易。值得注意的是，根据 InvestingPro ...

Rolph Timothy, the Chief Scientific Officer of Akero Therapeutics Inc . (NASDAQ:AKRO), recently executed a notable share sale ...

Graham G. Walmsley, a director at Akero Therapeutics, Inc. (NASDAQ:AKRO), recently acquired a significant amount of the company's common stock. According to a recent SEC filing, Walmsley purchased 200 ...

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at ...

NEW YORK CITY, NY / ACCESS Newswire / February 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

旧金山讯—根据最新的SEC文件显示，Akero Therapeutics, Inc. (NASDAQ: AKRO )董事Graham G. Walmsley于1月30日以每股48美元的价格购入了200,000股公司普通股，总价值960万美元。该公司股票在过去一年上涨了191%，目前交易价格为54.21美元，已为这位董事的投资带来可观收益。 InvestingPro ...

Roche Holding AG Akt 0.65% CHF232.25B ...

NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

AKRO opened at $54.08 on Friday. Akero Therapeutics has a 12-month low of $15.32 and a 12-month high of $58.40. The company has a current ratio of 17.25, a quick ratio of 17.25 and a debt-to ...